Ten-year cardiovascular risk in a hong kong population

European Journal of Preventive Cardiology

Volumn 6, Issue 3, 1999, Pages 163-169

  Chan, Wai K ^a   Chiu, Alexander ^a   Ko, Gary T C ^b   wu, Man F ^c   Liu, Fuk L ^c   Choi, Kim W ^c  

^a UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^b Tai Po Nethersole Hospital   (Hong Kong)

^c United Christian Nethersole Community Health Service Hong Knog   (Hong Kong)

Author keywords

cardiovascular risk factors; community health screening

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; FEMALE; HIGH RISK POPULATION; HONG KONG; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RISK; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SMOKING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; FEMALE; HONG KONG; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MASS SCREENING; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SMOKING;

EID: 84992863140     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/204748739900600307     Document Type: Article

References (37)

1. Annual report 1996/97 Hong Kong; Department of Health; 1997. pp. 72–73.
2. Thompson GR, Wilson PW. Coronary risk factors and their assessment. London: Science Press; 1992.
3. Castelli WP. Epidemiology of coronary heart disease; The Framingham Study. Am J Med 1984; 27: 4–12.
4. Hong Kong 1996 population by-census report. Hong Kong: Census and Statistics Department, Hong Kong Special Administrative Region; 1996.
5. American Heart Association Science Advisory, Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. Circulation 1997; 95: 2329–2331.
6. Diabetes Mellitus. Report of the World Health Organization Study Group. Technical Report Series No. 727. Geneva: World Health Organization; 1985.
7. Pyorala K, De Backer G, Graham I, Poole-Wilson P, Wood D. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Artherosclerosis Society and European Society of Hypertension. Eur Heart J 1994; 15: 1300–1331.
8. To CY, Donnan SPB. The cooperative cross-disciplinary research project on physical activities and quality of life in densely populated urban areas. Phase two study report (part one). Health risks, fitness and quality of life in adults in Hong Kong. Hong Kong: The Chinese University of Hong Kong; 1988.
9. Fong PC, Tam SC, Tai YT, Lau CP, Lee J, Sha YY, et al Serum lipid and apolipoprotein distributions in Hong Kong Chinese. J Epidemiol Commun Health 1994; 48: 356–361.
10. Chan WK, Lee YF, Kung NS, et al Prevalence of hypercholesterolemia and cigarette smoking in Hong Kong [abstract]. Eur Heart J 1994; 15 (suppl):610.
11. Brunner E, White I, Thorogood M, Bristow A, Curie D, Marmot M. Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. Am J Public Health 1997; 87: 1415–1422.
12. Naylor CD, Paterson JM. Cholesterol policy and the primary prevention of coronary disease: reflections on clinical and population strategies. Annu Rev Nutr 1996; 160: 349–382.
13. World Health Organization Collaborative Group. Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results. Eur Heart J 1983; 4: 141–147.
14. Frick ME, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, et al Helsinski Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237–1245.
15. Maher V, Sinfuego J, Chao P, Parekh J. Primary prevention of coronary heart disease: what has WOSCOPS told us and what question remain? Drugs 1997; 54: 1–8.
16. Haq IU, Jackson PR, Yeo WW, Ramsay LE. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease. Lancet 1995; 346: 1467–1471.
17. Kannel WB. Blood pressure as a cardiovascular risk factor. Prevention and treatment. JAMA 1996; 275: 1571–1576.
18. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255–3264.
19. Woo J, Ho SC, Yuen YK, Yu LM, Lau J. Cardiovascular risk factors and 18-month mortality and morbidity in an elderly Chinese population aged 70 years and over. Gerontology 1998; 44: 51–55.
20. Cupples LA, D'Agostino RB. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements. Framingham Heart Study: 30 year follow up. National Institutes of Health document: 87-2703. Washington, DC: US Dept of Health and Human Services, Public Health Services, National Heart, Lung and Blood Institute; 1987.
21. Lee PK, Li RK, Chan JC, Chang S, Lee SC, Tomlinson B, et al A prescription survey in a hospital hypertension outpatient clinic. Br J Clin Pharmacol 1997; 44: 577–582.
22. Kuczmarski RJ, Flegal KM, Campbell SM, Hohnson CL. Increasing prevalence of overweight among U.S. adults: The National Health and nutrition examination surveys, 1960–1991. JAMA 1994; 272: 205–211.
23. Ko GT, Chan JC, Woo J, Lan E, Yeung VT, Chow CC, et al Simple anthropometric indexes and cardiovascular risk factors in Chinese. Int J Obes Relet Metab Disord 1997; 21: 995–1001.
24. Lam TH, He Y, Li LS, He SF, Liang BQ. Mortality attributable to cigarette smoking in China. JAMA 1997; 278: 1505–1508.
25. US Dept of Health and Human Services. The health benefits of smoking cessation: a report of the surgeon general, 1990. Publication (CDC) 90-8416. Rockville, MD: US Dept of Health and Human Services; 1990.
26. Jonas MA, Oates JA, Ockene JK, Hennekens CH. Statement on smoking and cardiovascular disease for health care professionals. AHA Medical/Scientific Statement. Circulation 1992; 86: 1664–1669.
27. Manson JE, Tosteson H, Ridker PM, Satterfield S, Hebert P, O'Connor GT, et al The primary prevention of myocardial infarction. N Engl J Med 1992; 326: 1406–1416.
28. Doll R, Peto R. Mortality in relation to smoking: 20 years observation on male British doctors. BMJ 1976; 2: 1525–1536.
29. Willet WC, Green A, Stampfer MJ, Speizer FE, Colditz GA, Rosner B, et al Relative and absolute excess risks of coronary heart disease among women who smoke cigarettes. N Engl J Med 1987; 317: 1303–1309.
30. Ko GT, Chan JC, Lau E, Woo J, Cockram CS. Fasting plasma glucose as a screening test for diabetes and its relationship with cardiovascular risk factors in Hong Kong Chinese. Diabetes Care 1997; 20: 170–172.
31. Wild RA. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med 1995; 98 (suppl 1A): 27S–32S.
32. Chan JC, Cheung JC, Lau EM, Woo J, Chan AY, Swaminathan R, et al The metabolic syndrome in Hong Kong Chinese. The interrelationships among its components analyzed by structural equation modeling. Diabetes Care 1996; 19: 953–959.
33. Ko GT, Chan JC, Woo J, Lau EM, Yeung VT, Chow CC, et al The effect of age on cardiovascular risk factors in Chinese women. Int J Cardiol 1997; 61: 221–227.
34. Genest JJ, McNamara Jr., Salem DN, Schaefer EJ. Prevalence of risk factors in men with premature coronary artery disease. Am J Cardiol 1991; 67: 1185–1189.
35. Stamler J, Wentworth D, Neaton JD, for the MRFIT research group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256: 2823–2828.
36. Neaton JD, Wentworth D, for the MRFIT research group. Serum cholesterol, blood pressure, cigarette smoking and death from coronary heart disease: overall findings and differences by age for 316 099 white men. Arch Intern Med 1992; 152: 56–64.
37. Wilson JMG, Jungner G. The principles and practice of screening for disease. Public Health Papers, 34. Geneva: World Health Organization; 1968.